Provided by Tiger Trade Technology Pte. Ltd.

Therapeutics

4.59
-0.0900-1.92%
Post-market: 4.600.0100+0.22%19:38 EDT
Volume:497.91K
Turnover:2.29M
Market Cap:143.62M
PE:-1.11
High:4.70
Open:4.65
Low:4.55
Close:4.68
52wk High:50.40
52wk Low:4.54
Shares:31.29M
Float Shares:18.39M
Volume Ratio:0.84
T/O Rate:2.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1300
EPS(LYR):-2.8503
ROE:-59.21%
ROA:-37.36%
PB:0.66
PE(LYR):-1.61

Loading ...

Tempest Therapeutics Announces New Chief Financial Officer

TIPRANKS
·
4 hours ago

Grace Therapeutics Files for Resale of Up to 4.8 Million Shares

MT Newswires Live
·
4 hours ago

Grace Therapeutics files to sell 4.76M shares of common stock for holders

TIPRANKS
·
5 hours ago

Press Release: Oruka Therapeutics Appoints Todd Edwards as Chief Commercial Officer

Dow Jones
·
5 hours ago

Lineage Cell Therapeutics management to meet with B. Riley

TIPRANKS
·
8 hours ago

BioXcel Therapeutics Amends Credit Agreement, Extends Financing Deadline

TIPRANKS
·
Yesterday

Aquestive Therapeutics Price Target Maintained with a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
Yesterday

IMPACT Therapeutics to Join Hang Seng Composite Index

MT Newswires Live
·
Yesterday

Aptabio Therapeutics Partially Redeems and Cancels Private Convertible Bonds

TIPRANKS
·
Yesterday

ASX Flags Possible Delisting of Zelira Therapeutics Over Unpaid Listing Fees

TIPRANKS
·
Yesterday

Autolus Therapeutics Earnings Call Highlights Growth Momentum

TIPRANKS
·
Aug 23

Major Insider Move at CAMP4 Therapeutics Shakes Up Investor Buzz

TIPRANKS
·
Aug 22

Silexion Therapeutics Receives Nasdaq Delisting Notice, Plans Appeal

TIPRANKS
·
Aug 22

Tempest Therapeutics files to sell 8.91M shares of common stock for holders

TIPRANKS
·
Aug 22

Oruka Therapeutics Files $1 Billion Mixed Shelf

MT Newswires Live
·
Aug 22

Stoke Therapeutics Price Target Announced at $40.00/Share by JP Morgan

Dow Jones
·
Aug 22

Craig-Hallum Initiates Quince Therapeutics at Buy With $68 Price Target

MT Newswires Live
·
Aug 21

Ceryvyn Therapeutics Issues 7.2 Million Unquoted Long-Dated Options

TIPRANKS
·
Aug 21

Ipsen boosts hematology pipeline with Kartos Therapeutics acquisition

TIPRANKS
·
Aug 21

Alterity Therapeutics seeks ASX quotation for new ordinary shares

TIPRANKS
·
Aug 21